Professor Andrew Pettitt

Andrew studied Medicine at Cambridge (1983-1989) before taking up training posts in Internal Medicine (Nottingham, 1990-1992) and Haematology (Liverpool, 1992-1994). He joined the University of Liverpool as Clinical Lecturer in 1994 and was appointed as Senior Lecturer & Consultant Haematologist at the Royal Liverpool University Hospital in 2000. He was promoted to Reader in 2004 and Personal Chair in 2006. He was appointed Head of Department of Molecular and Clinical Cancer Medicine in 2011 and awarded the Ronald Finn Chair of Experimental Medicine in 2013. At national level, he chaired the UK CLL Forum from 2006-2012, was a member of the Cancer Research UK Clinical Trials and Awards Advisory Committee from 2009-2012 and was appointed Chair of the National Cancer Research Institute (NCRI) Haematological Oncology Clinical Studies Group (CSG) in 2012. Andrew is a Medical Advisor for Leukaemia & Lymphoma Research, the Lymphoma Association, Leukaemia Care and the CLL Support Association.

Andrew’s clinical and research interests are focused on lymphoid malignancy. He established local specialist services for patients with lymphoma and related disorders, together with the clinical research infrastructure required to deliver a large and continually evolving portfolio of early- and late-stage clinical trials. He plays a full and active role in delivering these services through out-patient clinics and ward attendance. At national level, Andrew has led several NCRI trials in lymphoma and chronic lymphocytic leukaemia (CLL), including two large phase 3 studies and a phase 2 study that was the first to apply stratified medicine to CLL. He also founded the UK CLL Trials Biobank, which played a pivotal role in attracting £3.5M from the DoH to sequence 1000 CLL genomes as a Pilot for the Genomics England 100,000 Genomes Project. Andrew’s laboratory research interests are focused on patient stratification and the development of predictive biomarkers. He has accumulated more than £8M of research income as PI since 2008.

Andrew is currently primary supervisor for 5 PhD students and co-supervisor for 7 others. He contributes to medical undergraduate teaching and junior medical staff training through clinical attachments, and he lectures on haematological malignancy as part of the dental undergraduate course.